![Kinji Fuchikami](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kinji Fuchikami
Directeur/Membre du Conseil chez
NapaJen Pharma, Inc.
Profil
Kinji Fuchikami is currently Director at NapaJen Pharma, Inc. Formerly, Mr. Fuchikami was Director at PROMETHERA Biosciences SA and Investment Partner at Mitsui & Co. Global Investment Ltd. from 2004 to 2010.
Mr. Fuchikami graduated from Osaka University in 1992.
Postes actifs de Kinji Fuchikami
| Sociétés | Poste | Début |
|---|---|---|
NapaJen Pharma, Inc.
 NapaJen Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery technology solutions through cellular transport pathways | Directeur/Membre du Conseil | 22/04/2011 |
Anciens postes connus de Kinji Fuchikami
| Sociétés | Poste | Fin |
|---|---|---|
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Directeur/Membre du Conseil | - |
Mitsui & Co. Global Investment Ltd.
 Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co invests in companies located in North America, Singapore, Japan and Europe. The firm focuses on healthcare and information technologies. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Formation de Kinji Fuchikami
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Osaka University
 Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mitsui & Co. Global Investment Ltd.
Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co invests in companies located in North America, Singapore, Japan and Europe. The firm focuses on healthcare and information technologies. It provides financing for seed and early stage capital requirements. | Finance |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
NapaJen Pharma, Inc.
NapaJen Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery technology solutions through cellular transport pathways | Health Technology |
